Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E WILCKEN

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|August 30, 1997
MTHFR 677C-->T mutation, folate intake, neural-tube defect, and risk of cardiovascular diseaseD E Wilcken
Australian and New Zealand Journal of Medicine|October 1, 1992
Genes, gender and geometry and the prolapsing mitral valveD E Wilcken
The American Journal of Cardiology|July 20, 1983
Local factors controlling coronary circulationD E Wilcken
Lancet (London, England)|July 1, 1989
Mitral valve prolapseD E Wilcken
The Medical Journal of Australia|June 5, 1998
Homocysteine and vascular diseaseD E Wilcken
Journal of Cardiovascular Risk|January 27, 1999
Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular diseaseD E Wilcken
The American Journal of Clinical Nutrition|August 2, 2000
Homocysteine and cardiovascular disease: cause or effect?L Brattström, D E Wilcken
Circulation Research|November 1, 1974
Reactive hyperemia in the dog heart. Effects of temporarily restricting arterial inflow and of coronary occlusions lasting one and two cardiac cyclesE Eikens, D E Wilcken
Circulation Research|September 1, 1973
Myocardial reactive hyperemia and coronary vascular reactivity in the dogE Eikens, D E Wilcken
Lancet (London, England)|June 20, 1970
Glucagon in resistant heart-failure and cardiogenic shockD E Wilcken, R Lvoff
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|August 30, 1997
MTHFR 677C-->T mutation, folate intake, neural-tube defect, and risk of cardiovascular diseaseD E Wilcken
Australian and New Zealand Journal of Medicine|October 1, 1992
Genes, gender and geometry and the prolapsing mitral valveD E Wilcken
The American Journal of Cardiology|July 20, 1983
Local factors controlling coronary circulationD E Wilcken
Lancet (London, England)|July 1, 1989
Mitral valve prolapseD E Wilcken
The Medical Journal of Australia|June 5, 1998
Homocysteine and vascular diseaseD E Wilcken
Journal of Cardiovascular Risk|January 27, 1999
Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular diseaseD E Wilcken
The American Journal of Clinical Nutrition|August 2, 2000
Homocysteine and cardiovascular disease: cause or effect?L Brattström, D E Wilcken
Circulation Research|November 1, 1974
Reactive hyperemia in the dog heart. Effects of temporarily restricting arterial inflow and of coronary occlusions lasting one and two cardiac cyclesE Eikens, D E Wilcken
Circulation Research|September 1, 1973
Myocardial reactive hyperemia and coronary vascular reactivity in the dogE Eikens, D E Wilcken
Lancet (London, England)|June 20, 1970
Glucagon in resistant heart-failure and cardiogenic shockD E Wilcken, R Lvoff
Pageof 16